Elevance Health Inc (ELV) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates in four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other.
Total Cash From Operating Activities Chart for Elevance Health Inc
Elevance Health Inc (ELV) operating cash flow for FY2025 was USD 4.3B, a -26.1% change from FY2024. Elevance Health Inc's operating cash flow grew from USD 684.5M in 2000 to USD 4.3B in 2025 (526.7% over 25 years). Operating cash flow compound annual growth rate: 5-year CAGR of -16.7%, 10-year CAGR of 0.4%, 20-year CAGR of 1.4%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $95.46B
- Implied Share Price
- $440.18
- Enterprise Value
- $107.25B
- Revenue (TTM)
- $201.11B
- EBITDA
- $8.32B
- Profit Margin
- 2.47%
- Trailing P/E
- 19.49
- Forward P/E
- 13.68
- Price/Book (MRQ)
- 1.93
- Price/Sales (TTM)
- 0.47
- EV/EBITDA
- 0.00
- EV/Revenue
- 0.53
- Dividend Yield
- 1.59%
- Book Value
- $206.99
- Free Cash Flow (FY2025)
- $3.17B
- Free Cash Flow Yield
- 3.32%
Snapshot as of 21st October 2026 — not point-in-time controlled, may lag the live market by a few days.